Flixotide

Medicinal product

(Invented) name

Flixotide

Active substance (s)

Flutikazonas

Strength

125 µg/dozėje

Pharmaceutical form

suslėgtoji įkvepiamoji suspensija

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03BA05, Fluticasone

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

1994-12-20

Date of renewal

2008-02-08

Documents

1013 Flixotide RPP 2025 04 09.docx

1013 Pakuotės lapelis 2025 04 09.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Flutikazonas	125 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
1176	781	1000781	slėginė talpyklė	60 dozių N1		Receptinis	LT/1/94/1013/003	Tiekiama	2025-03-25	-	No	-	-	Download

Stadijos

Data	Stadija
2008-02-08	Perregistruotas
1994-12-20	Registruotas